Belimumab in kidney transplantation

Affiliations

¹ B Department of Propaedeutic Surgery and Renal Transplant Center, Laikon General Hospital, National and Kapodistrian University of Athens, Athens 11527, Greece. Electronic address: actampaki@yahoo.com.
² Department of General and Visceral Surgery, Basel University Hospital, Basel, Switzerland.
³ Department of Vascular Surgery and Renal Transplant Center, Basel University Hospital, Basel, Switzerland.
⁴ Department of Pharmacology, National and Kapodistrian University of Athens, Athens 11527, Greece.

Comment

Ekaterini Christina Tampaki et al. Lancet. 2019.

. 2019 Mar 2;393(10174):874-875.

doi: 10.1016/S0140-6736(18)33075-7.

¹ B Department of Propaedeutic Surgery and Renal Transplant Center, Laikon General Hospital, National and Kapodistrian University of Athens, Athens 11527, Greece. Electronic address: actampaki@yahoo.com.
² Department of General and Visceral Surgery, Basel University Hospital, Basel, Switzerland.
³ Department of Vascular Surgery and Renal Transplant Center, Basel University Hospital, Basel, Switzerland.
⁴ Department of Pharmacology, National and Kapodistrian University of Athens, Athens 11527, Greece.

No abstract available

Comment in

Belimumab in kidney transplantation - Authors' reply.
Banham GD, Flint SM, Shanahan DN, Henderson RB, Clatworthy MR. Banham GD, et al. Lancet. 2019 Mar 2;393(10174):875-876. doi: 10.1016/S0140-6736(18)33066-6. Lancet. 2019. PMID: 30837145 No abstract available.

Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial.
Banham GD, Flint SM, Torpey N, Lyons PA, Shanahan DN, Gibson A, Watson CJE, O'Sullivan AM, Chadwick JA, Foster KE, Jones RB, Devey LR, Richards A, Erwig LP, Savage CO, Smith KGC, Henderson RB, Clatworthy MR. Banham GD, et al. Lancet. 2018 Jun 30;391(10140):2619-2630. doi: 10.1016/S0140-6736(18)30984-X. Epub 2018 Jun 14. Lancet. 2018. PMID: 29910042 Free PMC article. Clinical Trial.